Skip to main content

Peer Review reports

From: Lenalidomide based triplets in relapsed/refractory multiple myeloma: analysis of the Czech Myeloma Group

Original Submission
11 Feb 2025 Submitted Original manuscript
12 Feb 2025 Author responded Author comments - Jiri Minarik
18 Feb 2025 Reviewed Reviewer Report - Dongwei Sun
24 Feb 2025 Reviewed Reviewer Report
6 Mar 2025 Author responded Author comments - Jiri Minarik
Resubmission - Version 2
12 Feb 2025 Submitted Manuscript version 2
7 Mar 2025 Reviewed Reviewer Report
14 Mar 2025 Reviewed Reviewer Report - Dongwei Sun
25 Mar 2025 Author responded Author comments - Jiri Minarik
Resubmission - Version 3
25 Mar 2025 Submitted Manuscript version 3
28 Mar 2025 Author responded Author comments - Jiri Minarik
Resubmission - Version 4
28 Mar 2025 Submitted Manuscript version 4
2 Apr 2025 Author responded Author comments - Jiri Minarik
Resubmission - Version 5
2 Apr 2025 Submitted Manuscript version 5
2 Apr 2025 Author responded Author comments - Jiri Minarik
Resubmission - Version 6
2 Apr 2025 Submitted Manuscript version 6
2 Apr 2025 Author responded Author comments - Jiri Minarik
Resubmission - Version 7
2 Apr 2025 Submitted Manuscript version 7
Publishing
4 Apr 2025 Editorially accepted
9 Apr 2025 Article published 10.1186/s12885-025-14087-y

You can find further information about peer review here.

Back to article page